Lansobene

Lansoprazole, the active ingredient in Lansobene, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is used to manage acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adult patients. GNH USA supplies Lansobene as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansobene, a proton pump inhibitor, is employed to treat conditions caused by excess gastric acid. - Gastro‑oesophageal reflux disease (GERD): lowers acid exposure and promotes healing of the oesophageal lining. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence. - Helicobacter pylori eradication regimens: enhances the effectiveness of combination antibiotic therapy. - Erosive oesophagitis: reduces inflammation and promotes mucosal repair.

Adverse reactions may occur with Lansobene use. Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools occurring intermittently. - Nausea: feeling of stomach upset. - Abdominal pain: discomfort in the upper abdomen. Serious or Rare Side Effects: - Acute interstitial nephritis: signs of kidney inflammation. - Severe allergic reactions: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhoea with fever.

Before prescribing Lansobene, consider the following precautions. - Assess renal function: adjust use in severe impairment. - Evaluate hepatic status: monitor in patients with liver disease. - Review concomitant medications: potential for reduced efficacy of drugs requiring acidic pH. - Long‑term use: monitor for vitamin B12 deficiency and bone density loss. - Pregnancy and lactation: weigh benefits against potential risks. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Lansobene may interact with several medicines. Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased antiviral absorption. - Methotrexate (high dose): increased toxicity. Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR. - Digoxin: modest increase in serum levels. - Iron salts: reduced iron absorption when taken concurrently.